Occidental Is Good As It Didn't Cut Dividends - Cramer's Lightning Round (4/18/16)

|
Includes: AGN, CIEN, COP, IONS, OXY, RVNC
by: SA Editor Mohit Manghnani

Summary

Cramer was wrong on Ionis Pharmaceuticals.

Don't Buy Ciena.

Revance Therapeutics should not be this low.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, April 18.

Bullish Calls

ConocoPhillips (NYSE:COP): "I think ConocoPhillips is good, but I prefer Occidental (NYSE:OXY) as I like the dividend, and I like the fact that it did not cut it."

Revance Therapeutics (NASDAQ:RVNC): It's a lot like Allergan. It's down and everyone has given up on it. Cramer likes the stock.

Bearish Calls

Ionis Pharmaceuticals (NASDAQ:IONS): "Every time I recommend it, people get hurt. I have got it wrong."

Ciena (NASDAQ:CIEN): It's a negative.

:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.